NuVasive Becomes First Industry Sponsor of the American Spine Registry to Improve Future of Spine Surgery Through Data-Driven Outcomes

Rhea-AI Summary

NuVasive, Inc. (NASDAQ: NUVA) has become the first industry sponsor of the American Spine Registry (ASR) in a multi-year collaboration aimed at enhancing spine surgery through data-driven outcomes. This partnership is poised to improve evidence-based decision-making for over 1.2 million spine surgeries performed annually in the U.S. NuVasive will support data collection for quality tracking and benchmarking, benefitting spine surgeons and contributing to better patient outcomes.

Positive

• NuVasive's sponsorship enhances its leadership position in spine care.
• Collaboration with ASR expected to improve evidence-based decision-making.
• Registry data will support national benchmarking for spine surgery outcomes.

Negative

• None.

SAN DIEGO, July 17, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the 84%A2" rel="nofollow">American Spine Registry™ (ASR), a national quality improvement registry for spine care, today announced that they have entered into a multi-year sponsorship to improve the future of spine surgery through data-driven outcomes. ASR is a collaboration between the American Association of Neurological Surgeons (AANS) and the American Academy of Orthopaedic Surgeons (AAOS) and this arrangement with NuVasive marks the first-of-its-kind for the ASR, providing industry support to expand its data collection platform.

"NuVasive's founding sponsorship with the American Spine Registry is indicative of our leadership in spine care and our commitment to deliver better patient outcomes," said Kyle Malone, vice president of clinical, medical and regulatory affairs at NuVasive. "Led by two highly regarded surgical societies, the ASR extends benefits of systematic data collection nationwide to improve evidence-based decision making in spine."

As a key sponsor for the ASR, NuVasive will contribute to the future development of the registry, providing spine surgeons the ability to track the quality of their interventions through patient-reported and clinical outcomes, grant them access to national benchmarking data to compare performance across the country and support highly informed-decision making to enable surgeons to provide the highest quality of care.

"With a shared mission to improve outcomes in spine surgery, the ASR is proud to have NuVasive as the first industry contributor to our program. Together, we are poised to improve patient care and advance the science of spine surgery," said Dr. Steven Glassman, professor of orthopedics at the University of Louisville in Kentucky, former Scoliosis Research Society president and ASR executive committee co-chair.

The registry will allow spine surgeons, hospitals and ambulatory surgery centers to reuse registry data for participation in a variety of programs, including payer-incentivized performance improvement programs, qualify for national distinction programs and CMS quality improvement programs (MIPS and BPCI-A), as well as receive credits towards American Board of Orthopaedic Surgery (ABOS) and American Board of Neurological Surgery (ABNS) Continuous Certification programs.

"Degenerative spine disease is one of the most prevalent and costly disease states worldwide with common surgeries including spinal fusion and decompression or discectomy surgery," said Dr. Anthony Asher, president, neuroscience institute at Atrium Health in Charlotte, North Carolina, AANS officer and ASR executive committee co-chair. "With NuVasive leading the way in support of this mission, this sponsorship will help ASR to effectively influence the future of spine care for the more than 1.2 million spine surgeries that are performed nationally each year. We look forward to the lasting impact it will have on our program."

About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes access, implants and fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With more than $1 billion in revenue, NuVasive has approximately 2,800 employees and operates in more than 50 countries serving surgeons, hospitals and patients. For more information, please visit www.nuvasive.com.

About American Spine Registry
The American Spine Registry is a collaborative effort of the American Association of Neurological Surgeons and the American Academy of Orthopaedic Surgeons on a national quality improvement registry for spine care. Both organizations have joint ownership and leadership representation in this effort. The ASR provides spine surgeons across the country scalability, sustainability, ease-of-use and relevance of national spine data collection efforts and facilitates intelligent data use. For more information, please visit www.AmericanSpineRegistry.org.

Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA® platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

View original content to download multimedia:http://www.prnewswire.com/news-releases/nuvasive-becomes-first-industry-sponsor-of-the-american-spine-registry-to-improve-future-of-spine-surgery-through-data-driven-outcomes-301095343.html

SOURCE NuVasive, Inc.; American Spine Registry

FAQ

What is NuVasive's recent partnership about?

NuVasive has partnered with the American Spine Registry to improve spine surgery outcomes through data-driven strategies.

When was the NuVasive and ASR sponsorship announced?

The sponsorship was announced on July 17, 2020.

What are the goals of the American Spine Registry?

The goals of the ASR include improving patient care and advancing spine surgery through systematic data collection.

How will NuVasive's partnership with ASR benefit spine surgeons?

The partnership will provide spine surgeons with access to national benchmarking data, helping them track quality and improve decision-making.

What impact does the ASR have on the healthcare industry?

The ASR influences spine care quality and supports participation in payer-incentivized performance improvement programs.